![Eric Mosbrooker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Mosbrooker
Directeur/Membre du Conseil chez
National Pharmaceutical Council
Profil
Eric B. Mosbrooker is currently Director at National Pharmaceutical Council since 2018.
Formerly, Mr. Mosbrooker was Chief Commercial Officer at Avidity Biosciences, Inc. from 2025 to 2026, Chief Operations Officer at Cognoa, Inc. from 2021 to 2023, Chief Commercial Officer & Senior Vice President at Astellas Gene Therapies, Inc. from 2019 to 2021, Chief Commercial Officer at Origin Biosciences, Inc. in 2018, Senior Vice President-Orphan Business Unit & GM at Horizon Therapeutics Ltd. (Ireland) from 2017 to 2018, and Senior Vice President-Americas & Asia Pacific at Raptor Pharmaceuticals, Inc. in 2016.
Education includes undergraduate studies at the University of Wisconsin.
Postes actifs de Eric Mosbrooker
| Sociétés | Poste | Début |
|---|---|---|
National Pharmaceutical Council
 National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services Operates as a not for profit organization which specializes in research development, information dissemination, education and communication of information to patients | Directeur/Membre du Conseil | 06/03/2018 |
Anciens postes connus de Eric Mosbrooker
| Sociétés | Poste | Fin |
|---|---|---|
| AVIDITY BIOSCIENCES, INC. | Directeur/Membre du Conseil | 05/01/2024 |
Cognoa, Inc.
 Cognoa, Inc. Medical/Nursing ServicesHealth Services Offers a mobile app and proprietary algorithm to enable early detection of autism | Directeur des opérations | 01/02/2023 |
| AUDENTES THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2021 |
Origin Biosciences, Inc.
 Origin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Directeur des opérations | 01/12/2018 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | 01/04/2018 |
Formation de Eric Mosbrooker
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
45
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Avidity Biosciences, Inc.
 Avidity Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that provides research and development, administrative & investment services | Health Technology |
Horizon Therapeutics Ltd. (Ireland)
 Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Pharmaceutical Council
National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services Operates as a not for profit organization which specializes in research development, information dissemination, education and communication of information to patients | Commercial Services |
Raptor Pharmaceuticals, Inc.
 Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and markets life-altering therapeutics | Health Technology |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes gene therapy products for patients with serious rare diseases | Health Technology |
Cognoa, Inc.
Cognoa, Inc. Medical/Nursing ServicesHealth Services Offers a mobile app and proprietary algorithm to enable early detection of autism | Health Services |
Origin Biosciences, Inc.
Origin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
